Sonnet BioTherapeutics
SONN
SONN
9 hedge funds and large institutions have $1.17M invested in Sonnet BioTherapeutics in 2014 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.
Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WA
1
WFG Advisors
Dallas,
Texas
|
$48K |
Top Sellers
| 1 |
TDC
1
Thompson Davis & Co
Richmond,
Virginia
|
$400K |
| 2 |
U
2
UBS
Zurich,
Switzerland
|
$4K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$1K |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$44K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Millennium Management
New York
| $460K | 222,222 | – | – |
|
|
TDC
2
Thompson Davis & Co
Richmond,
Virginia
| $400K | 193,388 | -2,794 | -1% |
|
|
BIT
3
BlackRock Institutional Trust
San Francisco,
California
| $117K | 56,692 | – | – |
|
|
CDH
4
Charles D. Hyman
| $92K | 44,444 | – | – |
|
|
WA
5
WFG Advisors
Dallas,
Texas
| $48K | 23,332 | +15,000 | +180% |
|
|
6
Bank of America
Charlotte,
North Carolina
| $44K | 21,428 | -1 | -0% |
|
|
U
7
UBS
Zurich,
Switzerland
| $4K | 2,000 | -1,128 | -36% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $1K | 261 | -530 | -67% |
|
9
Morgan Stanley
New York
| $0 | 11 | – | – |
|